IN BRIEF: IP Group investee Hinge Health valued at over USD6 billion
IN BRIEF: IP Group investee Hinge Health valued at over USD6 billion
Read moreTue, 30th Mar 2021 07:53
IN BRIEF: IP Group investee Hinge Health valued at over USD6 billion
Read moreIN BRIEF: IP Group books GBP27.5 million fair value gain
Read more(Sharecast News) - Intellectual property-based business developer IP Group said on Monday that, following the completion of a funding round by a portfolio company in its top 20 most valuable holdings, it recorded a net realised and unrealised fair value gain of about £27.5m, or 2.6p per share.
Read moreOxford BioMedica licences technology for cystic fibrosis treatment
Read more(Sharecast News) - Gene and cell therapy firm Oxford Biomedica said on Tuesday that pharmaceutical giant Boehringer Ingelheim had exercised its option to license its lentiviral vector technology to manufacture, register and commercialise a treatment for cystic fibrosis.
Read moreIN BRIEF: Outgoing IP Group CEO Alan Aubrey buys 40,000 shares
Read moreLONDON MARKET MIDDAY: Shares fall as gas prices fuel inflation fear
Read more(Sharecast News) - IP Group said on Wednesday that chief executive Alan Aubrey and chief investment officer Mike Townend are retiring and stepping down from the board with immediate effect following the successful flotation of its largest holding, Oxford Nanopore Technologies.
Read moreTOP NEWS: Oxford Nanopore IPO prompts change at top at IP Group
Read moreLONDON MARKET MIDDAY: Stocks mixed; Oxford Nanopore soars on debut
Read moreUPDATE: Oxford Nanopore nears GBP5 billion value in London debut
Read more(Sharecast News) - Shares in Oxford Nanopore Technologies surged on Thursday after the British biotech made its £3.4bn debut on the London Stock Exchange.
Read moreTOP NEWS: Oxford Nanopore hits GBP4.6 billion value in London debut
Read moreLONDON MARKET CLOSE: Stocks up; airlines fly higher on sector optimism
Read more